Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias

Andrew R. Branagan(Massachusetts General Hospital), Madhav V. Dhodapkar(Emory University), Davit Witt(Yale Cancer Center), Dennis Cooper(Yale Cancer Center), Jeremy Kortmansky(Yale Cancer Center), Kavita M. Dhodapkar(Emory University), Connor Foster(Yale Cancer Center), Fangyong Li(Yale University), Rakesh Verma(Harvard University), Thomas Ferencz(Yale Cancer Center), Lin Zhang(The University of Melbourne), Stuart Seropian(Yale Cancer Center), Eamon Duffy(Auckland City Hospital), Terri L. Parker(Yale Cancer Center), Debra Brandt(Yale Cancer Center)
Blood Advances
March 8, 2021
Cited by 21


Related Papers